Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial.
Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial. Am Heart J. 1996 Aug; 132(2 Pt 1):314-8.
View in:
PubMed
subject areas
Adult
Anticoagulants
Female
Heparin
Humans
Infusions, Intravenous
Male
Middle Aged
Plasminogen Activators
Recombinant Proteins
Thrombolytic Therapy
Thrombosis
Treatment Outcome
Urokinase-Type Plasminogen Activator
authors with profiles
Samuel Zachary Goldhaber, M.D.